Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castleman's Disease, Multicentric”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Looking for participantsNCT07085039
What this trial is testing

Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman's Disease (CD)Idiopathic Multicentric Castleman's Disease
University of Pennsylvania 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT00092222
What this trial is testing

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Who this might be right for
Lymphoproliferative DisorderHHV-8Malignancy+1 more
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT02853968
What this trial is testing

Unlock the Cell: Castleman's Disease Flow Cytometry Study

Who this might be right for
Castleman DiseaseAngiofollicular Lymphoid HyperplasiaGLNH+4 more
University of Pennsylvania 130
Not applicableLooking for participantsNCT04968288
What this trial is testing

Natural History of KSHV-Associated Multicentric Castleman s Disease

Who this might be right for
Multicentric Castleman s Disease
National Cancer Institute (NCI) 195
Not applicableUnknownNCT05995834
What this trial is testing

Producing a Novel Symptom Burden Scale for People Living With Idiopathic Multicentric Castleman Disease (ISBUS)

Who this might be right for
Idiopathic Multicentric Castleman's Disease
RECORDATI GROUP 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03933904
What this trial is testing

Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's Disease, Multicentric
University of Pennsylvania 7
Not applicableLooking for participantsNCT00006518
What this trial is testing

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Who this might be right for
HIVKaposi's SarcomaLymphomas+2 more
National Cancer Institute (NCI) 1,029
Testing effectiveness (Phase 2)Study completedNCT01024036
What this trial is testing

Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease

Who this might be right for
Multicentric Castleman's Disease
Janssen Research & Development, LLC 79
Early research (Phase 1)Study completedNCT01183598
What this trial is testing

Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment

Who this might be right for
Castleman's Disease
Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05345522
What this trial is testing

Anti-IL-6R mAb Injection in Patients With iMCD

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Beijing VDJBio Co., LTD. 25
Post-approval studies (Phase 4)WithdrawnNCT00361933
What this trial is testing

Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease

Who this might be right for
Giant Lymph Node Hyperplasia
University of Washington
Testing effectiveness (Phase 2)Study completedNCT00132015
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)UnknownNCT03982771
What this trial is testing

BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD)

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01441063
What this trial is testing

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseMulticentric Castleman DiseaseGiant Lymph Node Hyperplasia
National Cancer Institute (NCI) 8
Not applicableLooking for participantsNCT05663502
What this trial is testing

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Who this might be right for
Anal CarcinomaHematopoietic and Lymphoid Cell NeoplasmHIV Infection+9 more
AIDS Malignancy Consortium 200
Early research (Phase 1)Ended earlyNCT02109224
What this trial is testing

Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaCutaneous B-Cell Non-Hodgkin Lymphoma+26 more
National Cancer Institute (NCI) 72
Not applicableWithdrawnNCT02871050
What this trial is testing

Castleman Disease Collaborative Network Biobank

Who this might be right for
Castleman DiseaseCastleman's DiseaseGiant Lymph Node Hyperplasia+6 more
Castleman Disease Collaborative Network
Not applicableLooking for participantsNCT02817997
What this trial is testing

International Registry for Patients With Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's DiseaseGiant Lymph Node Hyperplasia+6 more
University of Pennsylvania 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05907759
What this trial is testing

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Who this might be right for
Lymphoma, Primary Effusion
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT01400503
What this trial is testing

Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease

Who this might be right for
Multicentric Castleman's Disease
Janssen Research & Development, LLC 60
Load More Results